EXACT Therapeutics AS (OSL:EXTX)
Norway flag Norway · Delayed Price · Currency is NOK
0.6050
-0.1150 (-15.97%)
At close: Sep 11, 2026

EXACT Therapeutics AS Ratios and Metrics

Millions NOK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3887238385360522
Market Cap Growth
-72.99%-63.30%-38.21%6.94%-31.02%-40.97%
Enterprise Value
-1129223347283396
Last Close Price
0.601.383.7612.0012.0017.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
490.701479.72-86354.11791.9810035.84
PB Ratio
0.582.842.068.545.534.93
P/TBV Ratio
0.582.842.068.545.534.93

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-494.09-77902.05621.977610.71

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.010.030.030.02
Net Debt / Equity Ratio
-0.74-0.78-0.86-1.00-1.04-0.96
Net Debt / EBITDA Ratio
0.660.291.940.971.721.77
Net Debt / FCF Ratio
0.730.331.210.961.991.80
Asset Turnover
0.000.00-00.010
Quick Ratio
3.090.852.833.564.8110.57
Current Ratio
4.161.653.543.614.8110.57
Return on Equity (ROE)
-113.45%-118.93%-65.17%-87.74%-46.95%-44.15%
Return on Assets (ROA)
-51.64%-48.10%-30.80%-42.05%-25.47%-25.67%
Return on Capital Employed (ROCE)
-116.70%-276.40%-45.70%-105.60%-61.40%-55.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-198.02%-99.61%-22.00%-12.55%-11.14%-11.23%
FCF Yield
-175.21%-82.83%-34.49%-12.31%-9.47%-10.87%
Buyback Yield / Dilution
-74.89%-82.42%-8.10%-6.94%-0.06%-0.04%